By Sami Ramsammy and Matthew X. Lowe The Multiple Identities of Psychedelics Classic psychedelics, often referred to as hallucinogens, consist of
By Matthew X. Lowe, Research Director Originally published by Psychedelic Spotlight A new study looks at how an ayahuasca ceremony may help rebuild
By Matthew X Lowe, Ph.D. In recent years, the use of ayahuasca for both therapeutic and spiritual purposes has become more commonplace in
By Trey Brasher Beta-blockers are a class of drugs most commonly prescribed for reducing hypertension (lowering blood pressure) and widely considered one of the
By Trey Brasher & David Rosen, Ph.D. | 22 minute read Few discoveries in history have changed psychology more than the 1943
By Trey Brasher | 14 minute read On April 19th, 1943 in Basil, Switzerland, chemist Albert Hofmann took the world’s first trip on LSD. The
by Matthew X. Lowe, Ph.D., Director of Research for Unlimited Sciences Unlimited Sciences is a non-profit organization focused on driving psychedelics research forward, and
By Trey Brasher | 8 min read – (without the chemistry section) 3,4 methylenedioxymethamphetamine is perhaps one of the most coveted clandestinely produced chemical
By Trey Brasher | 10 min read In modern society, the drive for altered consciousness is most frequently treated as pathology. Although undoubtedly
Preliminary Findings from Our Real World Psilocybin Mushroom Study We are excited to reveal some preliminary results of our ongoing Real-World Psilocybin Mushroom Study
©2023 Unlimited Sciences. All rights reserved.
Our newsletter is meant to provide you with the latest news in psychedelic research, inform you about our work, and inspire you with compelling stories from all over the world about the power of psychedelics.